Adherence to generic v. brand antidepressant treatment and the key role of health system factors

Epidemiology and Psychiatric Sciences

Volumn 24, Issue 1, 2015, Pages 23-26

  Barbui, C ^a   Conti, V ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b Directorate General of Health of the Lombardy Region   (Italy)

Author keywords

Adherence; antidepressant; health system; policy

Indexed keywords

ANTIDEPRESSANT AGENT; GENERIC DRUG;

ARTICLE; DEPRESSION; FOLLOW UP; HEALTH CARE; HUMAN; MEDICARE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE;

EID: 84923802172     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S2045796014000754     Document Type: Article

References (18)

1. Abbing-Karahagopian V, Huerta C, Souverein PC, de Abajo F, Leufkens HG, Slattery J, Alvarez Y, Miret M, Gil M, Oliva B, Hesse U, Requena G, de Vries F, Rottenkolber M, Schmiedl S, Reynolds R, Schlienger RG, de Groot MC, Klungel OH, van Staa TP, van Dijk L, Egberts AC, Gardarsdottir H, De Bruin ML (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. European Journal of Clinical Pharmacology 70, 849-857.
2. Abuelkhair M, Abdu S, Godman B, Fahmy S, Malmstrom RE, Gustafsson LL (2012). Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi. Expert Review of Pharmacoeconomics and Outcomes Research 12, 115-124.
3. Bao Y, Ryan AM, Shao H, Pincus HA, Donohue JM (2013). Generic initiation and antidepressant therapy adherence under medicare part D. American Journal of Managed Care 19, 989-998.
4. Conti V, Lora A, Cipriani A, Fortino I, Merlino L, Barbui C (2012). Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders. European Journal of Clinical Pharmacology 68, 1647-1655.
5. Corrao G, Soranna D, La Vecchia C, Catapano A, Gabiti-Rosei E, Gensini G, Merlino L, Mancia G (2014). Medication persistence and the use of generic and brand-name blood pressure-lowering agents. Journal of Hypertension 32, 1146-1153.
6. Eaton J (2008). Ensuring access to psychotropic medication in sub-Saharan Africa. African Journal of Psychiatry 11, 179-181.
7. Godman B, Wettermark B, Fraeyman J, Varez-Madrazo S, Berg C, Bishop I, Bucsics A, Campbell S, Finlayson AE, Furst J, Garuoliene K, Herholz H, Kalaba M, Laius O, Piessnegger J, Sermet C, Schwabe U, Vlahovic-Palcevski VV, Markovic-Pekovic V, Voncina L, Malinowska K, Zara C, Gustafsson LL (2014). Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications. Frontiers in Pharmacology 5, 106.
8. Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen RD, Kochen MM, Gleiter CH, Hummers-Pradier E (2005). What do primary care patients think about generic drugs International Journal of Clinical Pharmacology and Therapeutics 43, 472-479.
9. Hung CI (2014). Factors predicting adherence to antidepressant treatment. Current Opinion in Psychiatry 27, 344-349.
10. Jones G (2003). Prescribing and taking medicines. BMJ 327, 819.
11. McCarthy M (2013). Antidepressant use has doubled in rich nations in past 10 years. BMJ 347, f7261.
12. Minas H, Cohen A (2007). Why focus on mental health systems International Journal of Mental Health Systems 1, 1.
13. Mojtabai R, Olfson M (2014). National trends in long-term use of antidepressant medications: results from the U.S. National Health and Nutrition Examination Survey. Journal of Clinical Psychiatry 75, 169-177
14. OSMED (2014). L'uso dei farmaci in Italia. Osservatorio nazionale sull'impiego dei medicinali: Rome.
15. Rothman K, Greenland S, Lash T (2008). Modern Epidemiology, 3rd edn. Lippincott, Williams & Wilkins: Philadelphia, PA.
16. Saraceno B (2007). Mental health systems research is urgently needed. International Journal of Mental Health System 1, 2.
17. Shrank WH, Hoang T, Ettner SL, Glassman PA, Nair K, DeLapp D, Dirstine J, Avorn J, Asch SM (2006). The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Archives of Internal Medicine 166, 332-337.
18. Vlahiotis A, Devine ST, Eichholz J, Kautzner A (2011). Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans. Journal of Managed Care Pharmacy 17, 123-132.